Related Experiment Video
Updated: Aug 4, 2026

10:58
Combinatorial Synthesis of and High-throughput Protein Release from Polymer Film and Nanoparticle Libraries
Published on: September 6, 2012
Controlled release of biologically active compounds from bioerodible polymers
Biomaterials
|January 1, 1980
Summary
This review explores how polymer erosion controls the release of active agents. It details mechanisms like cross-linked scission and hydrolysis, focusing on drug release from degrading matrices.
Area of Science:
- Biomaterials Science
- Polymer Chemistry
- Drug Delivery Systems
Background:
- Controlled release systems are crucial for therapeutic efficacy.
- Polymer matrices offer versatile platforms for incorporating and releasing active agents.
- Understanding polymer degradation mechanisms is key to designing effective drug delivery.
Purpose of the Study:
- To review the mechanisms of controlled release of biologically active agents from eroding polymer matrices.
- To discuss polymer erosion processes including cross-linked scission, hydrolysis, ionization, protonation, and backbone cleavage.
- To correlate drug release studies with specific polymer degradation pathways.
Main Methods:
- Review of scientific literature on polymer erosion and drug release.
- Categorization of drug release mechanisms based on polymer degradation pathways.
- Analysis of studies involving active agents incorporated within polymer matrices.
Main Results:
- Identified key polymer erosion mechanisms governing active agent release.
- Detailed the influence of cross-linked scission, hydrolysis, ionization, and backbone cleavage on release kinetics.
- Highlighted the importance of polymer matrix degradation in controlling drug diffusion and release.
Conclusions:
- Polymer erosion is a primary mechanism for controlled release of incorporated active agents.
- Specific degradation pathways dictate the rate and profile of drug release.
- Further research into tailoring polymer degradation can optimize drug delivery systems.
Related Concept Videos
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Bioplastics
Bioplastics derived from microbial processes present a sustainable alternative to conventional petroleum-based plastics. Among these, polyhydroxyalkanoates (PHAs), particularly polyhydroxybutyrates (PHBs), have emerged as prominent candidates due to their biodegradability and biocompatibility. These polymers are synthesized by a variety of bacteria, such as Cupriavidus necator and Pseudomonas putida, which naturally accumulate PHAs as intracellular carbon and energy reserves, especially under...

